Kay Clark

Randomized, Double-Blind, Multicenter Phase 2 Study Comparing the Efficacy and Safety of Oral Solithromycin (CEM-101) to Those of Oral Levofloxacin in the Treatment of Patients with Community-Acquired Bacterial Pneumonia

David Oldach, Kay Clark, Jennifer Schranz et al. · Antimicrobial Agents and Chemotherapy · 2013 · 78 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +13

Pharmacokinetics of Solithromycin (CEM-101) after Single or Multiple Oral Doses and Effects of Food on Single-Dose Bioavailability in Healthy Adult Subjects

James Still, Jennifer Schranz, Thorsten P. Degenhardt et al. · Antimicrobial Agents and Chemotherapy · 2011 · 63 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

Comparison of Plasma, Epithelial Lining Fluid, and Alveolar Macrophage Concentrations of Solithromycin (CEM-101) in Healthy Adult Subjects

Keith A. Rodvold, Mark H. Gotfried, James Still et al. · Antimicrobial Agents and Chemotherapy · 2012 · 51 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +9

A Randomized, Double-Blind Phase 2 Study Comparing the Efficacy and Safety of an Oral Fusidic Acid Loading-Dose Regimen to Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections

J. Carl Craft, Susan Moriarty, Kay Clark et al. · Clinical Infectious Diseases · 2011 · 46 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Population Pharmacokinetics of Fusidic Acid: Rationale for Front-Loaded Dosing Regimens Due to Autoinhibition of Clearance

Jürgen B. Bulitta, Ólanrewaju O. Okusanya, Alan Forrest et al. · Antimicrobial Agents and Chemotherapy · 2012 · 44 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17